Lista de obras - Paola Fadda - Dominio Público Uruguay

An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives.

artículo científico publicado en 2006

Analysis of opioid-seeking reinstatement in the rat.

artículo científico publicado en 2015

Antinociceptive action of DBO 17 and DBO 11 in mice: two 3,8 diazabicyclo (3.2.1.) octane derivates with selective μ opioid receptor affinity ⬇️

artículo científico publicado el 1 de noviembre de 1997

Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat

scientific journal article

Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat.

artículo científico publicado en 2014

Benzocondensed derivatives as rigid analogues of the mu-opioid agonist 3(8)-cinnamyl-8(3)-propionyl-3,8-diazabicyclo[3.2.1]octanes: synthesis, modeling, and affinity.

artículo científico publicado en 1998

Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2.

artículo científico publicado en 2007

Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors

scientific journal article

CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat

artículo científico publicado en 2004

Cannabinoid CB1 /CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia.

artículo científico publicado en 2017

Cannabinoid self-administration increases dopamine release in the nucleus accumbens.

artículo científico publicado en 2006

Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs.

scientific article published on April 2010

Cannabinoids and reward: interactions with the opioid system.

artículo científico publicado en 2004

Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation

artículo científico publicado en 2012

Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.

artículo científico publicado en 2012

Chronic imipramine, L-sulpiride and mianserin decrease corticotropin releasing factor levels in the rat brain

scientific article published on 01 June 1995

Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.

artículo científico publicado en 2011

Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats

artículo científico publicado en 2004

Dopamine D1 and opioid receptor binding changes in the limbic system of sleep deprived rats.

artículo científico publicado en 1992

Dopamine and opioids interactions in sleep deprivation.

artículo científico publicado en 1993

Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones.

artículo científico publicado en 2010

Endocannabinoid system and opioid addiction: behavioural aspects.

artículo científico publicado en 2005

Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms

artículo científico publicado en 2014

Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa

scientific article published on 10 April 2020

Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats

artículo científico publicado en 2008

Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward

artículo científico publicado en 2007

Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzo

artículo científico publicado en 2007

Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones.

artículo científico publicado en 2013

Methoxetamine affects brain processing involved in emotional response in rats.

artículo científico publicado en 2017

Monocyclic analogues of the μ-opioid agonist 3,8-diazabicyclo [3.2.1]octanes: Synthesis, modeling, and activity

N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as mu-opioid receptor agonists. Effects on mu-affinity of arylalkenyl chain modifications.

artículo científico publicado en 2002

Neurobiological mechanisms of cannabinoid addiction.

artículo científico publicado en 2008

PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors.

artículo científico publicado en 2013

Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.

artículo científico publicado en 2013

Reduction of corticostriatal glutamatergic fibers in basic fibroblast growth factor deficient mice is associated with hyperactivity and enhanced dopaminergic transmission.

artículo científico publicado en 2006

Role of opioid receptors in the reinstatement of opioid-seeking behavior: an overview

artículo científico

Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts.

artículo científico publicado en 2006

Sex differences in addictive disorders

artículo científico

Sex differences in the self-administration of cannabinoids and other drugs of abuse.

artículo científico publicado en 2009

Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats.

artículo científico publicado en 2006

Stress-induced sleep deprivation modifies corticotropin releasing factor (CRF) levels and CRF binding in rat brain and pituitary.

artículo científico publicado en 1997

Synthesis and mu-opioid receptor affinity of a new series of nitro substituted 3,8-diazabicyclo[3.2.1]octane derivatives.

artículo científico publicado en 1998

The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats

artículo científico publicado en 2012

The endocannabinoid system: a new molecular target for the treatment of tobacco addiction.

artículo científico publicado en 2008

The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidence.

artículo científico publicado en 2013

Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity

artículo científico publicado en 2014

Lista de obras de Paola Fadda

An endocannabinoid mechanism in relapse to drug seeking: a review of animal studies and clinical perspectives.

Analysis of opioid-seeking reinstatement in the rat.

Antinociceptive action of DBO 17 and DBO 11 in mice: two 3,8 diazabicyclo (3.2.1.) octane derivates with selective μ opioid receptor affinity ⬇️

Baclofen antagonizes nicotine-, cocaine-, and morphine-induced dopamine release in the nucleus accumbens of rat

Behavioural and neurochemical assessment of salvinorin A abuse potential in the rat.

Benzocondensed derivatives as rigid analogues of the mu-opioid agonist 3(8)-cinnamyl-8(3)-propionyl-3,8-diazabicyclo[3.2.1]octanes: synthesis, modeling, and affinity.

Bidirectional regulation of mu-opioid and CB1-cannabinoid receptor in rats self-administering heroin or WIN 55,212-2.

Blockade of nicotine reward and reinstatement by activation of alpha-type peroxisome proliferator-activated receptors

CB1 receptor agonist and heroin, but not cocaine, reinstate cannabinoid-seeking behaviour in the rat

Cannabinoid CB1 /CB2 receptor agonists attenuate hyperactivity and body weight loss in a rat model of activity-based anorexia.

Cannabinoid self-administration increases dopamine release in the nucleus accumbens.

Cannabinoid-opioid interactions in drug discrimination and self-administration: effect of maternal, postnatal, adolescent and adult exposure to the drugs.

Cannabinoids and reward: interactions with the opioid system.

Chronic blockade of CB(1) receptors reverses startle gating deficits and associated neurochemical alterations in rats reared in isolation

Chronic cannabinoid exposure reduces phencyclidine-induced schizophrenia-like positive symptoms in adult rats.

Chronic imipramine, L-sulpiride and mianserin decrease corticotropin releasing factor levels in the rat brain

Differential effect of opioid and cannabinoid receptor blockade on heroin-seeking reinstatement and cannabinoid substitution in heroin-abstinent rats.

Differential effects of THC- or CBD-rich cannabis extracts on working memory in rats

Dopamine D1 and opioid receptor binding changes in the limbic system of sleep deprived rats.

Dopamine and opioids interactions in sleep deprivation.

Drug- and cue-induced reinstatement of cannabinoid-seeking behaviour in male and female rats: influence of ovarian hormones.

Endocannabinoid system and opioid addiction: behavioural aspects.

Enhanced self-administration of the CB1 receptor agonist WIN55,212-2 in olfactory bulbectomized rats: evaluation of possible serotonergic and dopaminergic underlying mechanisms

Epigenetic regulation of the cannabinoid receptor CB1 in an activity-based rat model of anorexia nervosa

Inhibition of anandamide hydrolysis by cyclohexyl carbamic acid 3'-carbamoyl-3-yl ester (URB597) reverses abuse-related behavioral and neurochemical effects of nicotine in rats

Involvement of kappa-opioid and endocannabinoid system on Salvinorin A-induced reward

Long-term reduction of brain-derived neurotrophic factor levels and signaling impairment following prenatal treatment with the cannabinoid receptor 1 receptor agonist (R)-(+)-[2,3-dihydro-5-methyl-3-(4-morpholinyl-methyl) pyrrolo[1,2,3-de]-1,4-benzo

Male and female rats differ in brain cannabinoid CB1 receptor density and function and in behavioural traits predisposing to drug addiction: effect of ovarian hormones.

Methoxetamine affects brain processing involved in emotional response in rats.

Monocyclic analogues of the μ-opioid agonist 3,8-diazabicyclo [3.2.1]octanes: Synthesis, modeling, and activity

N-3(9)-arylpropenyl-N-9(3)-propionyl-3,9-diazabicyclo[3.3.1]nonanes as mu-opioid receptor agonists. Effects on mu-affinity of arylalkenyl chain modifications.

Neurobiological mechanisms of cannabinoid addiction.

PPARα regulates cholinergic-driven activity of midbrain dopamine neurons via a novel mechanism involving α7 nicotinic acetylcholine receptors.

Pharmacological modulation of the endocannabinoid signalling alters binge-type eating behaviour in female rats.

Reduction of corticostriatal glutamatergic fibers in basic fibroblast growth factor deficient mice is associated with hyperactivity and enhanced dopaminergic transmission.

Role of opioid receptors in the reinstatement of opioid-seeking behavior: an overview

Scopolamine and MK801-induced working memory deficits in rats are not reversed by CBD-rich cannabis extracts.

Sex differences in addictive disorders

Sex differences in the self-administration of cannabinoids and other drugs of abuse.

Strain and schedule-dependent differences in the acquisition, maintenance and extinction of intravenous cannabinoid self-administration in rats.

Stress-induced sleep deprivation modifies corticotropin releasing factor (CRF) levels and CRF binding in rat brain and pituitary.

Synthesis and mu-opioid receptor affinity of a new series of nitro substituted 3,8-diazabicyclo[3.2.1]octane derivatives.

The anandamide transport inhibitor AM404 reduces the rewarding effects of nicotine and nicotine-induced dopamine elevations in the nucleus accumbens shell in rats

The endocannabinoid system: a new molecular target for the treatment of tobacco addiction.

The role of the endocannabinoid system in eating disorders: neurochemical and behavioural preclinical evidence.

Δ9-tetrahydrocannabinol prevents methamphetamine-induced neurotoxicity